FDA Grants Fast Track Designation to BBO-11818 in KRAS+ Pancreatic Cancer

Rákkutatás · Pancreatic cancer

None

None

None

Bizonyítékszint: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.

Eredeti forrás

Kapcsolódó jelek

• Pancreatic cancer
• Modified FOLFIRINOX improves survival compared to gemcitabine in resected pancreatic cancer
• Recent Advances in the Treatment of Pancreatic Cancer
• Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
• EUROPAC Researching Hereditary Pancreatic Diseases